• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Infectious Disease

Continuous infusion of beta-lactams may be superior to bolus therapy

bys25qthea
January 9, 2013
in Infectious Disease, Surgery
Reading Time: 4 mins read
Share on FacebookShare on TwitterShare on LinkedIn

Jan 9th – Continuous infusion of beta-lactam antibiotics yielded a higher plasma concentration and higher rates of clinical cure in patients with severe sepsis. [tabs tab1=”2MM Rundown” tab2=”Full 2MM Report” tab3=”About the Authors”]

[tab]

Image: PD

1.  Continuous infusion of beta-lactam antibiotics yielded a higher plasma concentration and higher rates of clinical cure than bolus therapy in patients with severe sepsis.

 2.  Survival to hospital discharge was greater in patients who received continuous infusion, though this result was not statistically significant.

This is the first multicenter randomized control trial comparing continuous and intermittent administration of beta-lactams in critically ill patients.  The results suggest a benefit in administering beta-lactams continuously in order to maintain plasma concentrations above the MIC.  This study’s limitations primarily stem from the small cohort of patients enrolled, confounding by unmeasured factors, and lack of power to evaluate an effect on survival.  However, this study demonstrates the feasibility of performing a larger multicenter trial in an effort to determine the optimal method of administering beta-lactams in critically ill patients.

RELATED REPORTS

Social isolation and loneliness is associated with worse physical and mental health among middle-aged and older adults

Gait analysis predicts health, sleep, and medication use across 18 body systems

Click to read the study in Clinical Infectious Diseases

Click to read an accompanying editorial in CID

[/tab]

[tab]

Image: PD

1.  Continuous infusion of beta-lactam antibiotics yielded a higher plasma concentration and higher rates of clinical cure than bolus therapy in patients with severe sepsis.

2.  Survival to hospital discharge was greater in patients who received continuous infusion, though this result was not statistically significant.

Primer:  Sepsis is a systemic condition resulting from infection that is a significant cause of mortality worldwide.  In the United States, more than 650,000 cases of sepsis are diagnosed annually.  Estimated mortality rates from severe sepsis can range from 20-50%.  Treating sepsis involves early administration of antibiotics, fluid resuscitation, and often, mechanical ventilation.  The most common bacteriocidal antibiotics used in the setting of sepsis are beta-lactams, which kill bacteria by inhibiting cell wall synthesis.  The longer beta-lactam levels in the blood are above the drug’s Minimum Inhibitory Concentration (MIC – the lowest concentration of drug in which bacteria are unable to grow) the more effective they are at killing bacteria.  Therefore, continuously infusing beta lactams into the blood in order to maintain a steady concentration should yield better results than intermittently bolusing a drug.  The authors of this study compared continuous infusion therapy with bolus therapy in septic patients.

Background reading:

1. Clinical Outcomes with Extended or Continuous Versus Short-term Intravenous Infusion of Carbapemens and Piperacillin/Tazobactam: A systematic Review and Meta-analysis

2.  Uptodate: Sepsis and the systemic inflammatory response syndrome: Definitions, epidemiology, and prognosis

This [double-blind, randomized controlled] study enrolled a total of 60 patients who were in severe sepsis between 2010 and 2011.  Patients were randomized to receive either continuous infusion therapy with piperacillin-tazobactam, meropenem, or ticarcillin-clavulanate or bolus therapy with the same drugs.  Total drug dosages were similar between forms of therapy.  The researchers then measured plasma antibiotic concentrations, clinical cure, ICU length of stay, and hospital survival rates.  The proportion of patients in the intervention group who had a plasma concentration above MIC on days 3 and 4 was 82%, compared to 29% in the control group (p=0.001).  Clinical cure was higher in the intervention group (p= 0.032).  While ICU length of stay and hospital survival were both more favorable in the intervention group, these results were not statistically significant.

In sum: This is the first multicenter randomized control trial comparing continuous and intermittent administration of beta-lactams in critically ill patients.  The results suggest a benefit in administering beta-lactams continuously in order to maintain plasma concentrations above the MIC.  This study’s limitations primarily stem from the small cohort of patients enrolled, confounding by unmeasured factors, and lack of power to evaluate an effect on survival.  However, this study demonstrates the feasibility of performing a larger multicenter trial in an effort to determine the optimal method of administering beta-lactams in critically ill patients.

Click to read the study in Clinical Infectious Diseases

Click to read an accompanying editorial in CID

By [AS] and [MP]

© 2012 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. Content is produced in accordance with fair use copyrights solely and strictly for the purpose of teaching, news and criticism. No benefit, monetary or otherwise, is realized by any participants or the owner of this domain. 

[/tab]

[tab]

Akira Shishido: Aki is a 4th year M.D. candidate at Harvard Medical School.

 

 

 

 

Mitalee Patil: Mitalee is a 4th year M.D. candidate at Harvard Medical School.

 

 

 

 

[/tab]

[/tabs]

Previous Post

High rates of readmission and recurrence from elective incisional hernia repairs

Next Post

Levonorgestrel IUD superior to medical therapy in the non-surgical treatment of menorrhagia

RelatedReports

Aging collage: a smiling older man beside an hourglass, folded reading glasses and a pair of walking shoes
Chronic Disease

Social isolation and loneliness is associated with worse physical and mental health among middle-aged and older adults

November 18, 2026
A sleeping teenager depicted in bed with a clock and graphics illustrating growth patterns, highlighting the importance of sleep for adolescent growth and health.
Artificial Intelligence

Gait analysis predicts health, sleep, and medication use across 18 body systems

November 18, 2026
Comparison of two types of bariatric surgery: a sleeve gastrectomy represented by a drawn stomach outline and a gastric band represented by a stomach with a band.
Chronic Disease

Bariatric surgery associated with lower obesity-related cancer incidence in Nordic cohort

November 18, 2026
Bladder health collage: an anatomical drawing of the bladder with its ureters and urethra beside a water droplet
2MM Trial Briefs

Cretostimogene reduced recurrence risk in intermediate-risk and high-grade Ta non-muscle invasive bladder cancer in topline phase 3 results

November 18, 2026
Next Post

Levonorgestrel IUD superior to medical therapy in the non-surgical treatment of menorrhagia

Video surveillance sheds light on causes of falls in the elderly

Treating proximal humeral fractures: Reverse shoulder arthroplasty provides superior long term functional outcomes vs. hemiarthroplasty

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Social isolation and loneliness is associated with worse physical and mental health among middle-aged and older adults
  • Gait analysis predicts health, sleep, and medication use across 18 body systems
  • Bariatric surgery associated with lower obesity-related cancer incidence in Nordic cohort
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.